Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-14

Clinical Trial Update: Early Extubation by ECCO2R Compared to IMV in Patients with Severe Acute Exacerbation of COPD [NA]

View source ↗

Summary

A clinical trial comparing early extubation using extracorporeal CO2 removal (ECCO2R) with invasive mechanical ventilation in patients with severe acute exacerb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ECCO2R (extracorporeal CO2 removal)

Snippet

Sponsor: Xenios AG | Conditions: COPD Exacerbation | NA | Status: TERMINATED